2-Methyl-4-amine-5-((4-(((5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyrimidine

ID: ALA3775250

PubChem CID: 127030525

Max Phase: Preclinical

Molecular Formula: C18H15F3N8OS

Molecular Weight: 448.43

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1ncc(Cn2cc(CSc3nnc(-c4ccc(C(F)(F)F)cc4)o3)nn2)c(N)n1

Standard InChI:  InChI=1S/C18H15F3N8OS/c1-10-23-6-12(15(22)24-10)7-29-8-14(25-28-29)9-31-17-27-26-16(30-17)11-2-4-13(5-3-11)18(19,20)21/h2-6,8H,7,9H2,1H3,(H2,22,23,24)

Standard InChI Key:  QCVSVBVANQXQIY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    1.2990   -0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3383    1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -2.7000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6003   -1.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990   -0.7455    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2526   -1.3618    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2524   -0.2436    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4979    1.0528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0317    0.7358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0997    2.4249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2115    3.6347    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8144    5.0092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0510    6.2856    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0508    7.4038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4233    6.7985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2717    5.3062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7337    8.8707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3483    9.4327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1425   10.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3264   11.8396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7160   11.2749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9218    9.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1205   13.3262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0091   13.7787    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0678   14.0628    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9564   14.5150    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  6  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 17  2  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
 25 28  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3775250

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 448.43

Molecular Weight (Monoisotopic): 448.1042

AlogP: 3.37

#Rotatable Bonds: 6

Polar Surface Area: 121.43

Molecular Species: NEUTRAL

HBA: 10

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 5.97

CX LogP: 2.70

CX LogD: 2.68

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.44

Np Likeness Score: -2.10

References

1. He H, Wang W, Zhou Y, Xia Q, Ren Y, Feng J, Peng H, He H, Feng L..  (2016)  Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.,  24  (8): [PMID:26972920] [10.1016/j.bmc.2016.03.011]

Source

Source(1):

• Scientific Literature